The Rising Tide Of EU Antitrust Enforcement In Pharma
On Oct. 31, the European Commission fined Teva Pharmaceutical Industries Ltd. €463 million ($503 million at the exchange rate when the fine was issued) for abusing its dominant position to delay...To view the full article, register now.
Already a subscriber? Click here to view full article